Genski
Thorsten Genski, Verona IT
Patent application number | Description | Published |
---|---|---|
20090042897 | Chemical Compounds - The present invention relates to novel compounds or a pharmaceutically acceptable salt or solvate thereof, selected from a group consisting of: | 02-12-2009 |
20100197699 | I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating Disorders - The present invention relates to novel compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, | 08-05-2010 |
20100216821 | Benzimidazoles With A Hetero Spiro-Decane Residue As NPY-Y5 Antagonists - The present invention relates to compounds of formula (I), or a pharmaceutically acceptable salts, solvates, stereoisomers thereof, | 08-26-2010 |
20100286151 | 1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders - The present invention relates to novel compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, | 11-11-2010 |
Thorsten Genski, C/o Verona IT
Patent application number | Description | Published |
---|---|---|
20090203705 | Spiro Compounds As NPY Y5 Receptor Antagonists - The present invention relates to novel compounds of formula (I), or a pharmaceutically acceptable salt thereof, | 08-13-2009 |
Thorsten Genski, Potsdam DE
Patent application number | Description | Published |
---|---|---|
20130035321 | COMPOUNDS FOR THE TREATMENT OF OCULAR CANCER - In one aspect, the instant invention provides novel compounds and pharmaceutical compositions useful for treating proliferative diseases such as cancer. In another aspect, the invention provides methods of using certain compounds in the treatment of proliferative diseases such as cancer. In particular, the instant invention provides methods of treating ocular cancer (e.g., retinoblastoma) using intraarterial infusion to administer inventive compounds locally to the eye of a subject with an ocular cancer. | 02-07-2013 |